{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:36:33Z","timestamp":1787319393108,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22dm0307101"],"award-info":[{"award-number":["22dm0307101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24wm0625503"],"award-info":[{"award-number":["24wm0625503"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002770","name":"Cabinet Office, Government of Japan","doi-asserted-by":"publisher","award":["JPMJMS2024-9"],"award-info":[{"award-number":["JPMJMS2024-9"]}],"id":[{"id":"10.13039\/501100002770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["202111056A"],"award-info":[{"award-number":["202111056A"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24H00068"],"award-info":[{"award-number":["24H00068"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02744"],"award-info":[{"award-number":["18H02744"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18KT0027"],"award-info":[{"award-number":["18KT0027"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18KK0242"],"award-info":[{"award-number":["18KK0242"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K19512"],"award-info":[{"award-number":["22K19512"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02986"],"award-info":[{"award-number":["22H02986"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Data"],"DOI":"10.1038\/s41597-024-03909-6","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T07:02:55Z","timestamp":1728975775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson\u2019s disease patients"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0546-4670","authenticated-orcid":false,"given":"Zhiyang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatou","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Sasazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei-Ichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-5367","authenticated-orcid":false,"given":"Genko","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-0444","authenticated-orcid":false,"given":"Taku","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayami","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Souma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsushi","family":"Kataura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-2556","authenticated-orcid":false,"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"3909_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30, 1591\u2013601 (2015).","journal-title":"Mov Disord"},{"key":"3909_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17, 939\u2013953 (2018).","journal-title":"Lancet Neurol"},{"key":"3909_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo, Y. et al. The epidemiology of Parkinson\u2019s disease. The Lancet 403, 283\u2013292 (2024).","journal-title":"The Lancet"},{"key":"3909_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(24)00094-1","volume":"403","author":"The Lancet","year":"2024","unstructured":"The Lancet. What next in Parkinson\u2019s disease? The Lancet 403, 219 (2024).","journal-title":"The Lancet"},{"key":"3909_CR5","doi-asserted-by":"crossref","unstructured":"Pearson, C. et al. Care access and utilization among medicare beneficiaries living with Parkinson\u2019s disease. npj Parkinsons Dis. 9 (2023).","DOI":"10.1038\/s41531-023-00523-y"},{"key":"3909_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R., Sherer, T., Okun, M. S. & Bloem, B. R. The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis 8, S3\u2013S8 (2018).","journal-title":"J Parkinsons Dis"},{"key":"3909_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA 323, 548\u2013560 (2020).","journal-title":"JAMA"},{"key":"3909_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.26510","volume":"93","author":"K Miyamoto","year":"2023","unstructured":"Miyamoto, K. et al. Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD. Ann Neurol 93, 303\u2013316 (2023).","journal-title":"Ann Neurol"},{"key":"3909_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149620","volume":"703","author":"Y Ishiguro","year":"2024","unstructured":"Ishiguro, Y. et al. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson\u2019s pathology. Biochem Biophys Res Commun 703, 149620 (2024).","journal-title":"Biochem Biophys Res Commun"},{"key":"3909_CR10","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo, M. et al. Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease. Brain 143, 1476\u20131497 (2020).","journal-title":"Brain"},{"key":"3909_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/ana.26421","volume":"92","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. Parkinson\u2019s Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice. Ann Neurol 92, 230\u2013245 (2022).","journal-title":"Ann Neurol"},{"key":"3909_CR12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease. Cell 167, 1469\u20131480.e12 (2016).","journal-title":"Cell"},{"key":"3909_CR13","doi-asserted-by":"crossref","unstructured":"Romano, S. et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. npj Parkinsons Dis. 7 (2021).","DOI":"10.1038\/s41531-021-00156-z"},{"key":"3909_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris, H. R., Spillantini, M. G., Sue, C. M. & Williams-Gray, C. H. The pathogenesis of Parkinson\u2019s disease. The Lancet 403, 293\u2013304 (2024).","journal-title":"The Lancet"},{"key":"3909_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"X-Y Qin","year":"2016","unstructured":"Qin, X.-Y., Zhang, S.-P., Cao, C., Loh, Y. P. & Cheng, Y. Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis. JAMA Neurol 73, 1316\u20131324 (2016).","journal-title":"JAMA Neurol"},{"key":"3909_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","volume":"78","author":"T Mitchell","year":"2021","unstructured":"Mitchell, T. et al. Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review. JAMA Neurol 78, 1262\u20131272 (2021).","journal-title":"JAMA Neurol"},{"key":"3909_CR17","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1212\/WNL.0000000000011805","volume":"96","author":"G Lamotte","year":"2021","unstructured":"Lamotte, G. & Benarroch, E. E. What Is the Clinical Correlation of Cardiac Noradrenergic Denervation in Parkinson Disease? Neurology 96, 748\u2013753 (2021).","journal-title":"Neurology"},{"key":"3909_CR18","doi-asserted-by":"crossref","unstructured":"Matsubara, T. et al. Autopsy Validation of the Diagnostic Accuracy of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease. Neurology 98 (2022).","DOI":"10.1212\/WNL.0000000000200110"},{"key":"3909_CR19","doi-asserted-by":"crossref","unstructured":"Bega, D. et al. Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis. npj Parkinsons Dis. 7 (2021).","DOI":"10.1038\/s41531-021-00185-8"},{"key":"3909_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01685-8","volume":"22","author":"K Miyazaki","year":"2023","unstructured":"Miyazaki, K. et al. An exosome-based liquid biopsy signature for pre-operative identification of lymph node metastasis in patients with pathological high-risk T1 colorectal cancer. Mol Cancer 22, 2 (2023).","journal-title":"Mol Cancer"},{"key":"3909_CR21","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1182\/blood-2016-09-742296","volume":"129","author":"S Manier","year":"2017","unstructured":"Manier, S. et al. Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood 129, 2429\u20132436 (2017).","journal-title":"Blood"},{"key":"3909_CR22","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2022.06.090","volume":"163","author":"K Nakamura","year":"2022","unstructured":"Nakamura, K. et al. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. Gastroenterology 163, 1252\u20131266.e2 (2022).","journal-title":"Gastroenterology"},{"key":"3909_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel, D. M. & Gould, S. J. Exosomes. Annu Rev Biochem 88, 487\u2013514 (2019).","journal-title":"Annu Rev Biochem"},{"key":"3909_CR24","doi-asserted-by":"crossref","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367 (2020).","DOI":"10.1126\/science.aau6977"},{"key":"3909_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","volume":"13","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics 13, 17\u201324 (2015).","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"3909_CR26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","volume":"24","author":"R Shang","year":"2023","unstructured":"Shang, R., Lee, S., Senavirathne, G. & Lai, E. C. microRNAs in action: biogenesis, function and regulation. Nat Rev Genet 24, 816\u2013833 (2023).","journal-title":"Nat Rev Genet"},{"key":"3909_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature23282","volume":"548","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature 548, 52\u201357 (2017).","journal-title":"Nature"},{"key":"3909_CR28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","volume":"171","author":"W Ying","year":"2017","unstructured":"Ying, W. et al. Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity. Cell 171, 372\u2013384.e12 (2017).","journal-title":"Cell"},{"key":"3909_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature21365","volume":"542","author":"T Thomou","year":"2017","unstructured":"Thomou, T. et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature 542, 450\u2013455 (2017).","journal-title":"Nature"},{"key":"3909_CR30","doi-asserted-by":"crossref","unstructured":"He, S. et al. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson\u2019s disease. Transl Neurodegener 10 (2021).","DOI":"10.1186\/s40035-021-00249-y"},{"key":"3909_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.parkreldis.2021.11.020","volume":"93","author":"I Manna","year":"2021","unstructured":"Manna, I. et al. Exosomal miRNA as peripheral biomarkers in Parkinson\u2019s disease and progressive supranuclear palsy: A pilot study. Parkinsonism Relat Disord 93, 77\u201384 (2021).","journal-title":"Parkinsonism Relat Disord"},{"key":"3909_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2473-5","volume":"11","author":"H-X Chen","year":"2020","unstructured":"Chen, H.-X. et al. Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy. Cell Death Dis 11, 288 (2020).","journal-title":"Cell Death Dis"},{"key":"3909_CR33","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.ymthe.2022.06.003","volume":"30","author":"M Esteves","year":"2022","unstructured":"Esteves, M. et al. MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson\u2019s disease. Mol Ther 30, 3176\u20133192 (2022).","journal-title":"Mol Ther"},{"key":"3909_CR34","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox, S. H. et al. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov Disord 33, 1248\u20131266 (2018).","journal-title":"Mov Disord"},{"key":"3909_CR35","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1212\/WNL.0000000000012868","volume":"97","author":"T Pringsheim","year":"2021","unstructured":"Pringsheim, T. et al. Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology 97, 942\u2013957 (2021).","journal-title":"Neurology"},{"key":"3909_CR36","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","volume":"361","author":"CW Olanow","year":"2009","unstructured":"Olanow, C. W. et al. A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease. N Engl J Med 361, 1268\u201378 (2009).","journal-title":"N Engl J Med"},{"key":"3909_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1474-4422(11)70073-4","volume":"10","author":"O Rascol","year":"2011","unstructured":"Rascol, O. et al. A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol 10, 415\u201323 (2011).","journal-title":"Lancet Neurol"},{"key":"3909_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.parkreldis.2018.08.024","volume":"60","author":"N Hattori","year":"2019","unstructured":"Hattori, N. et al. Rasagiline monotherapy in early Parkinson\u2019s disease: A phase 3, randomized study in Japan. Parkinsonism Relat Disord 60, 146\u2013152 (2019).","journal-title":"Parkinsonism Relat Disord"},{"key":"3909_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00702-018-1964-3","volume":"126","author":"N Hattori","year":"2019","unstructured":"Hattori, N. et al. Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson\u2019s disease. J Neural Transm 126, 299\u2013308 (2019).","journal-title":"J Neural Transm"},{"key":"3909_CR40","unstructured":"Zhiyang, Y., Shinji, S. & Nobutaka, H. GEO https:\/\/identifiers.org\/geo\/GSE269781 (2024)."},{"key":"3909_CR41","unstructured":"Zhiyang, Y., Shinji, S. & Nobutaka, H. GEO https:\/\/identifiers.org\/geo\/GSE269775 (2024)."},{"key":"3909_CR42","unstructured":"Zhiyang, Y., Shinji, S. & Nobutaka, H. GEO https:\/\/identifiers.org\/geo\/GSE269776 (2024)."},{"key":"3909_CR43","unstructured":"Zhiyang, Y., Shinji, S. & Nobutaka, H. GEO https:\/\/identifiers.org\/geo\/GSE269777 (2024)."},{"key":"3909_CR44","unstructured":"Zhiyang, Y., Shinji, S. & Nobutaka, H. GEO https:\/\/identifiers.org\/geo\/GSE269779 (2024)."},{"key":"3909_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ana.25516","volume":"86","author":"S Saiki","year":"2019","unstructured":"Saiki, S. et al. A metabolic profile of polyamines in parkinson disease: A promising biomarker. Ann Neurol 86, 251\u2013263 (2019).","journal-title":"Ann Neurol"},{"key":"3909_CR46","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/mds.28068","volume":"35","author":"H Takeshige-Amano","year":"2020","unstructured":"Takeshige-Amano, H. et al. Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. Mov Disord 35, 1438\u20131447 (2020).","journal-title":"Mov Disord"},{"key":"3909_CR47","doi-asserted-by":"crossref","unstructured":"Fujimaki, M. et al. Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease. Neurology 90 (2018).","DOI":"10.1212\/WNL.0000000000004888"},{"key":"3909_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35271","volume":"10","author":"M Ishiguro","year":"2024","unstructured":"Ishiguro, M. et al. Genetic and clinical study of PARK7 in Japanese Parkinson\u2019s disease. Heliyon 10, e35271 (2024).","journal-title":"Heliyon"},{"key":"3909_CR49","doi-asserted-by":"crossref","unstructured":"Tezuka, T. et al. Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson\u2019s disease. npj Parkinsons Dis. 8 (2022).","DOI":"10.1038\/s41531-022-00367-y"},{"key":"3909_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106571","volume":"199","author":"T Tezuka","year":"2024","unstructured":"Tezuka, T. et al. Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson\u2019s disease. Neurobiology of Disease 199, 106571 (2024).","journal-title":"Neurobiology of Disease"},{"key":"3909_CR51","doi-asserted-by":"publisher","unstructured":"Tsunemi, T., Ishiguro, Y., Yoroisaka, A. & Hattori, N. Analysis of \u03b1-Synuclein in Exosomes. Methods in Molecular Biology 41\u201345 https:\/\/doi.org\/10.1007\/978-1-0716-1495-2_4 (Springer US, 2021).","DOI":"10.1007\/978-1-0716-1495-2_4"},{"key":"3909_CR52","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara, A., Birgaoanu, M. & Griffiths-Jones, S. miRBase: from microRNA sequences to function. Nucleic Acids Res 47, D155\u2013D162 (2019).","journal-title":"Nucleic Acids Res"},{"key":"3909_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat Methods 9, 357\u2013359 (2012).","journal-title":"Nat Methods"},{"key":"3909_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.parkreldis.2020.12.017","volume":"83","author":"T Mishima","year":"2021","unstructured":"Mishima, T. et al. Meta-iodobenzylguanidine myocardial scintigraphy in Perry disease. Parkinsonism & Related Disorders 83, 49\u201353 (2021).","journal-title":"Parkinsonism & Related Disorders"},{"key":"3909_CR55","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2021.12.014","volume":"114","author":"H Yoshino","year":"2022","unstructured":"Yoshino, H. et al. Genotype-phenotype correlation of Parkinson\u2019s disease with PRKN variants. Neurobiology of Aging 114, 117\u2013128 (2022).","journal-title":"Neurobiology of Aging"},{"key":"3909_CR56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jns.2017.12.030","volume":"385","author":"A Nakajima","year":"2018","unstructured":"Nakajima, A. et al. Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson\u2019s disease: A pilot study of DATSCAN for subthalamic deep brain stimulation. J Neurol Sci 385, 134\u2013139 (2018).","journal-title":"J Neurol Sci"},{"key":"3909_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.parkreldis.2022.08.011","volume":"103","author":"N Nishikawa","year":"2022","unstructured":"Nishikawa, N. et al. Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study. Parkinsonism Relat Disord 103, 129\u2013135 (2022).","journal-title":"Parkinsonism Relat Disord"},{"key":"3909_CR58","doi-asserted-by":"crossref","unstructured":"Uehara, Y. et al. Non-invasive diagnostic tool for Parkinson\u2019s disease by sebum RNA profile with machine learning. Sci Rep 11 (2021).","DOI":"10.1038\/s41598-021-98423-9"},{"key":"3909_CR59","doi-asserted-by":"crossref","unstructured":"Greenacre, M. et al. Principal component analysis. Nat Rev Methods Primers 2 (2022).","DOI":"10.1038\/s43586-022-00184-w"},{"key":"3909_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3447755","volume":"54","author":"FL Gewers","year":"2021","unstructured":"Gewers, F. L. et al. Principal Component Analysis. ACM Comput. Surv. 54, 1\u201334 (2021).","journal-title":"ACM Comput. Surv."},{"key":"3909_CR61","doi-asserted-by":"crossref","unstructured":"Marini, F. & Binder, H. pcaExplorer: an R\/Bioconductor package for interacting with RNA-seq principal components. BMC Bioinformatics 20 (2019).","DOI":"10.1186\/s12859-019-2879-1"},{"key":"3909_CR62","doi-asserted-by":"publisher","first-page":"W521","DOI":"10.1093\/nar\/gkaa309","volume":"48","author":"F Kern","year":"2020","unstructured":"Kern, F. et al. miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems. Nucleic Acids Res 48, W521\u2013W528 (2020).","journal-title":"Nucleic Acids Res"},{"key":"3909_CR63","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s43587-021-00042-6","volume":"1","author":"F Kern","year":"2021","unstructured":"Kern, F. et al. Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson\u2019s disease progression. Nat Aging 1, 309\u2013322 (2021).","journal-title":"Nat Aging"},{"key":"3909_CR64","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3909_CR65","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.tig.2023.01.003","volume":"39","author":"K Zhao","year":"2023","unstructured":"Zhao, K. & Rhee, S. Y. Interpreting omics data with pathway enrichment analysis. Trends Genet 39, 308\u2013319 (2023).","journal-title":"Trends Genet"},{"key":"3909_CR66","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson 3rd","year":"2023","unstructured":"Wilson, D. M. 3rd et al. Hallmarks of neurodegenerative diseases. Cell 186, 693\u2013714 (2023).","journal-title":"Cell"},{"key":"3909_CR67","doi-asserted-by":"publisher","unstructured":"Hodge, K. & Saethang, T. WhatIsMyGene: Back to the Basics of Gene Enrichment https:\/\/doi.org\/10.1101\/2023.10.31.564902 (2023).","DOI":"10.1101\/2023.10.31.564902"},{"key":"3909_CR68","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1074\/mcp.RA118.000735","volume":"17","author":"J Makjaroen","year":"2018","unstructured":"Makjaroen, J. et al. Comprehensive Proteomics Identification of IFN-\u03bb3-regulated Antiviral Proteins in HBV-transfected Cells. Mol Cell Proteomics 17, 2197\u20132215 (2018).","journal-title":"Mol Cell Proteomics"},{"key":"3909_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41420-023-01333-0","volume":"9","author":"C Diener","year":"2023","unstructured":"Diener, C. et al. Time-resolved RNA signatures of CD4+ T cells in Parkinson\u2019s disease. Cell Death Discov 9, 18 (2023).","journal-title":"Cell Death Discov"},{"key":"3909_CR70","unstructured":"Ot\u00e1vio N, Adriane H. GEO. https:\/\/identifiers.org\/geo\/GSE157239 (2020)."},{"key":"3909_CR71","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mds.27542","volume":"34","author":"C Starhof","year":"2019","unstructured":"Starhof, C. et al. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes. Mov Disord 34, 246\u2013254 (2019).","journal-title":"Mov Disord"},{"key":"3909_CR72","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/biomedicines11030764","volume":"11","author":"A Pellegrino","year":"2023","unstructured":"Pellegrino, A. et al. Differential Expression of microRNAs in Serum of Patients with Chronic Painful Polyneuropathy and Healthy Age-Matched Controls. Biomedicines 11, 764 (2023).","journal-title":"Biomedicines"}],"container-title":["Scientific Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41597-024-03909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41597-024-03909-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41597-024-03909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T07:04:37Z","timestamp":1728975877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41597-024-03909-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3909"],"URL":"https:\/\/doi.org\/10.1038\/s41597-024-03909-6","relation":{},"ISSN":["2052-4463"],"issn-type":[{"value":"2052-4463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1128"}}